newsfilter
← Latest News
PR Newswire·

Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London

  • Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that CFO Bill Peters & EVP of Corporate Administration Jacob Liawatidewi will attend the Jefferies Global Healthcare Conference in London.
  • The Analyst-Moderated fireside chat is scheduled for Wednesday, November 18, 2026, at 12:00 pm GMT.
  • The webcast will be accessible via Amphastar's investor relations website at http://ir.amphastar.com for 30 days post-event.
  • Amphastar develops, manufactures, & commercializes generic & proprietary injectable, inhalation, & intranasal products while also selling active pharmaceutical ingredients.
  • The company's finished products are primarily distributed through group purchasing organizations, drug wholesalers, & drug retailers.
  • Forward-looking statements in the release are based on current expectations & are subject to risks & uncertainties detailed in SEC filings, including the 10-K filed February 26, 2026, & 10-Qs filed May 7, August 6, & November 5, 2026.
Company
Amphastar Pharmaceuticals, Inc.
Keywords
Amphastar Pharmaceuticals, Inc.